Nelli Bejanyan, MD
Moffitt Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Nelli Bejanyan, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:40 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05015426 · Gamma Delta T-cell Infusion for AML at High Risk of Relapse After Allo HCTH. Lee Moffitt Cancer Center and Research Institute · active not recruiting · Acute Myeloid Leukemia · principal investigator
- Ph2NCT04191187 · Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic MalignanciesH. Lee Moffitt Cancer Center and Research Institute · completed · Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:40 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in childhood acute lymphoblastic leukemia.